NCT04606316 2026-02-17Surgical Nivolumab And Ipilimumab For Recurrent GBMDana-Farber Cancer InstitutePhase 1 Active not recruiting63 enrolled
NCT02981940 2025-09-02A Study of Abemaciclib in Recurrent GlioblastomaDana-Farber Cancer InstitutePhase 2 Active not recruiting45 enrolled 10 charts
NCT03189420 2024-04-19Glioma Microenvironment an Exploratory StudyHospital Sirio-LibanesActive not recruiting30 enrolled